Articles related to MEDTECH

Digital tools are emerging modalities for behavior modification in major depressive disorder, chronic insomnia, and substance use disorders. These evidence-based therapeutic software systems intervene in the prevention, management, or treatment of a medical disorder or disease. Examples of digital therapeutics include apps that deliver cognitive behavior therapy for chronic insomnia or psychoeducation for opioid use disorder. Because digital tools capture real-time patient data they can provide clinicians with a more accurate picture of a patient’s mental status or treatment progress than one-time self-reports during office visits.

Neurology referrals for headache are often unnecessary and delay appropriate headache care. A Geisinger Medical Center neurologist developed a tool that pops up on the EMR when the diagnosis of headache is entered. It guides with questions and suggested medications. The tool was developed in response to a chart review showing that referrals for headache from PCPs did not regularly document enough data in their notes on headache to reach a viable diagnosis nor were they regularly trying medications before referring.

Elham Hatef, MD, a clinical informatician at the Johns Hopkins Center for Population Health IT, discussed the findings of her recent study, “Outcomes of in-person and telehealth ambulatory encounters during COVID-19 within a large commercially insured cohort,” in this Q&A with Psych Congress Network.

Many traditional mental health treatments are now viewed as being risky, intrusive, and barbarous in comparison to modern science because healthcare has advanced significantly over time. Here are five of the most extreme treatments for mental illness in recorded history, along with an examination of how some of them influenced more reputable approaches used in modern therapies.

Dr. Janos Tanyi, Associate Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania, is joined by Dr. Charles Turck to discuss fluorescence-guided, intraoperative imaging as well as a new imaging drug to help physicians better detect ovarian cancer.

This 1.25-credit CME course provides a review and update of current practice on minimally invasive vs. open pancreaticoduodenectomy, including trends and outcomes in robotic and laparoscopic pancreaticoduodenectomy.